<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Cook Medical News</title><link>http://www.cookmedical.com/newsroom.do</link><description>Cook Medical News Releases</description><language>en_US</language><copyright>Copyright COOK 2012</copyright><webMaster>webmaster@cook-inc.com</webMaster><pubDate>Mon, 9 Apr 2012 00:00:00 EDT</pubDate><generator>jRSSGenerator by Henrique A. Viecili</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><image><url>http://www.cookmedical.com/img/favicon.gif</url><title>Cook Medical News</title><link>http://www.cookmedical.com</link><width>88</width><height>31</height></image><item><title>Cook Group Forms Cook General BioTechnology, LLC</title><link>http://www.cookmedical.com/newsDetail.do?id=7606</link><description>Bloomington, IN, April 9, 2012 &amp;#8212; As part of its ongoing commitment to patients needing emerging new cellular therapies, Cook Group has acquired the assets of General BioTechnology LLC and launched a new company, Cook General BioTechnology LLC (CGBT). Based in Indianapolis, CGBT adds valuable new cell and tissue processing and cryopreservation technologies to Cook Group&amp;#39;s existing cellular therapies and manufacturing portfolio that includes Cook MyoSite, Cook Pharmica and Cook Biotech. Details of the acquisition including the cost were not released.</description><author>David McCarty</author><pubDate>Mon, 9 Apr 2012 00:00:00 EDT</pubDate></item><item><title>Cook Medical Launches New Biopsy Needle Products at Society of Interventional Radiology Annual Scientific Meeting</title><link>http://www.cookmedical.com/newsDetail.do?id=7514</link><description>San Francisco, Calif., March 26, 2012 &amp;#81212; Cook Medical is pleased to announce the introduction of two bone biopsy products, the Osteo-Site&amp;#174; Ratchet&amp;#8482; and the Osteo-Site&amp;#174; coaxial bone biopsy needle set, at the Society of Interventional Radiology&amp;#39;s (SIR) 37th Annual Scientific Meeting in San Francisco. The launch of these new devices further amplifies Cook&amp;#39;s full line of bone biopsy needles while emphasizing Cook&amp;#39s commitment to interventional radiology by meeting the diverse procedural needs of this medical specialty.   </description><author>Marsha Lovejoy</author><pubDate>Mon, 26 Mar 2012 00:00:00 EDT</pubDate></item><item><title>Cook Medical Receives Japanese Approval to Market Its Zilver&amp;#174; PTX&amp;#174; Drug&amp;#45;Eluting Stent</title><link>http://www.cookmedical.com/newsDetail.do?id=7512</link><description>Bloomington, Ind., March 1, 2012 &amp;#8212; In a development that brings advanced combination therapy treatment of peripheral artery disease (PAD) to Japanese patients for the first time, Cook Medical has received PMDA approval to sell the Zilver&amp;#174; PTX&amp;#174; Drug-Eluting Peripheral Stent in Japan. The device, indicated for treating PAD in the superficial femoral artery (SFA), is the first stent available in Japan approved for use in the SFA. Its approval also makes Zilver PTX the only drug-eluting peripheral stent available in that country.</description><author>David McCarty</author><pubDate>Thu, 1 Mar 2012 00:00:00 EST</pubDate></item><item><title>Cervical Ripening Balloon from Cook Medical Now Available with Stylet</title><link>http://www.cookmedical.com/newsDetail.do?id=7510</link><description>Bloomington, Ind. &amp;#8212; Cook Medical&amp;#39;s Cervical Ripening Balloon will now be available with a guiding stylet that offers added stiffness to facilitate placement when conditions for inducing labor are unfavorable. The addition of a stylet helps obstetricians position the balloon exactly where it needs to be. The balloon is inserted approximately 12 hours before a planned induction to stimulate natural dilation of the cervix and provides a method for cervical ripening as an alternative to pharmaceuticals and their risk of potential side effects.</description><author>Caitlin Wenz</author><pubDate>Tue, 7 Feb 2012 00:00:00 EST</pubDate></item><item><title>Cardinal Health and Cook Medical Announce Exclusive Agreement for Customizable Vascular Access Kitting Solution</title><link>http://www.cookmedical.com/newsDetail.do?id=7509</link><description>Dublin, Ohio, February 2, 2012 &amp;#8212; Cardinal Health and Cook Medical today announced a two-year, exclusive agreement for the North American distribution of Cook Medical central venous catheter (CVC) sets with Cardinal Health Presource&amp;#174; customizable procedural kits &amp;#8211; providing clinicians with advanced technology the flexibility of customization for their vascular access needs.</description><author>Corey Kerr</author><pubDate>Wed, 1 Feb 2012 00:00:00 EST</pubDate></item><item><title>Cook Medical Renews Contract with Premier Healthcare Alliance, Extends Pricing Agreements on Specialty Urology Products for More than 2,500 U.S. Hospitals</title><link>http://www.cookmedical.com/newsDetail.do?id=7508</link><description>Bloomington, Ind. &amp;#8212; Hospitals around the country have three more years of access to a specialty urology agreement with an extensive line of specialty urology products at special pricing after Cook Medical and the Premier healthcare alliance renewed their contract to provide Cook&amp;#39;s urology products to more than 2,500 hospitals.</description><author>Caitlin Wenz</author><pubDate>Mon, 23 Jan 2012 00:00:00 EST</pubDate></item><item><title>Cook Medical Japan and Medico&amp;#39;s Hirata Collaborate to Establish New Distribution Model</title><link>http://www.cookmedical.com/newsDetail.do?id=7507</link><description>Cook Japan Incorporated and Medico&amp;#39;s Hirata announce their joint commitment to restructure their medical device distribution route as of April 1st 2012 in order to provide more specialized support to Japanese subdealers, medical institutions and physicians.</description><author>Eriko Aihara</author><pubDate>Mon, 16 Jan 2012 00:00:00 EST</pubDate></item><item><title>Cook Medical invests &amp;#8364;16.5m in R&amp;#38;D in Ireland</title><link>http://www.cookmedical.com/newsDetail.do?id=7506</link><description>Dublin, January 5th 2012 &amp;#8211; Minister for Jobs, Enterprise and Innovation Richard Bruton TD today announced that Cook Medical, the largest privately owned medical device company in the world, is to invest up to &amp;#8364;16.5m over four years creating highly skilled positions in Research and Development activities at its Limerick site, with Government support through IDA Ireland.</description><author>Linda Murphy</author><pubDate>Thu, 5 Jan 2012 00:00:00 EST</pubDate></item><item><title>Arthur D. Smith Endourology Lectureship Awarded to Dr. Matthew Gettman</title><link>http://www.cookmedical.com/newsDetail.do?id=7406</link><description>Kyoto, Japan, December 5, 2011 &amp;#8211;  Matthew T. Gettman, M.D., program director of the Mayo Clinic&amp;#39;s Department of Urology, has been awarded the 2011 Arthur D. Smith Endourology Lectureship. The award, known as the &amp;#8220;Arthur&amp;#8221; award, was given at the  29th World Congress of Endourology (WCE) in Kyoto, Japan, this week. Gettman was chosen specifically for his academic contributions to the field of urology, particularly his extensive research and expertise in the fields of robotic and laparoscopic surgery. The Endourological Society&amp;#39;s awards committee presents the Arthur award each year, and Cook Medical sponsors the award in honor of the lifetime achievements of Dr. Arthur D. Smith.</description><author>Caitlin Wenz</author><pubDate>Mon, 5 Dec 2011 00:00:00 EST</pubDate></item><item><title>Cook Medical is Awarded New Contract with Novation for Cook Central Venous Catheters</title><link>http://www.cookmedical.com/newsDetail.do?id=7407</link><description>Bloomington, Ind. December 6, 2011 &amp;#8211; Beginning January 1, 2012, Cook Medical&amp;#8217;s central venous catheters (CVCs) will be available to the members served by Novation, the supply contracting company for more than 30,000 members of VHA Inc., UHC, and Provista. This expands nationwide access to these devices through one of industry&amp;#8217;s leading health care supply contracting companies.</description><author>Marsha Lovejoy</author><pubDate>Mon, 5 Dec 2011 00:00:00 EST</pubDate></item><item><title>Cook Medical wins inaugural Limerick Region Company of the Year Award</title><link>http://www.cookmedical.com/newsDetail.do?id=7308</link><description>Limerick, Ireland, October 28, 2011 &amp;#8211; Cook Medical&amp;#39;s valuable place among the business community in Limerick has been recognised by Limerick Chamber at the inaugural Limerick Region Business Awards with Cook Ireland winning Company of the Year and Best Foreign Direct Investment Company at the award ceremony on Friday, October 21.</description><author>Linda Murphy</author><pubDate>Fri, 28 Oct 2011 00:00:00 EDT</pubDate></item><item><title>New Stent Provides Relief to Patients with Advanced Small Intestine Cancer</title><link>http://www.cookmedical.com/newsDetail.do?id=7306</link><description>October 17, 2011 &amp;#8211; Cook Medical announced today that it&amp;#8217;s Evolution&amp;#174; Duodenal Controlled&amp;#45;Release Stent was recently granted 510&amp;#40;k&amp;#41; clearance by the Food &amp;#38; Drug Administration &amp;#40;FDA&amp;#41;. This new stent expands palliative care options for patients experiencing issues associated with malignant gastric outlet obstruction &amp;#40;GOO&amp;#41;, a late stage complication of a variety of GI related cancers with pancreatic cancer being the most common cause.&amp;#185; Studies indicate that as many as 50 percent of the malignancies involving the small intestine, including pancreatic, gastric, duodenal and cholangiocarcinoma, occur in the duodenum,&amp;#178; the part of the small intestine connected to the stomach. The stent offers these patients a minimally invasive alternative to relieve the symptoms and potentially life&amp;#45;threatening complications resulting from duodenal obstruction, such as abdominal pain, vomiting, malnutrition and aspiration.</description><author>Caitlin Wenz</author><pubDate>Mon, 17 Oct 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical&amp;#8217;s Zilver&amp;#174; PTX&amp;#174; Drug-Eluting Stent Technology Receives Unanimous Recommendation from FDA Advisory Committee</title><link>http://www.cookmedical.com/newsDetail.do?id=7307</link><description>Gaithersburg, MD &amp;#8211; October 13, 2011 &amp;#8211; The Zilver&amp;#174; PTX&amp;#174; Drug&amp;#45;Eluting Stent, the first device of its kind developed to treat peripheral artery disease &amp;#40;PAD&amp;#41; in the superficial femoral artery &amp;#40;SFA&amp;#41;, has received a unanimous recommendation from the Food and Drug Administration&amp;#8217;s &amp;#40;FDA&amp;#41; Circulatory System Devices Panel of the Medical Devices Advisory Committee, Cook Medical announced today. The panel convened today in the Washington, DC area and all 11 of its members voted to recommend approval of the device on the basis of its safety, efficacy and acceptable risk profile. The recommendation is the latest step in the regulatory review process that the company hopes will ultimately lead to FDA approval to sell the Zilver PTX stent in the U.S.</description><author>David McCarty</author><pubDate>Fri, 14 Oct 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical To Present Zilver&amp;#174; PTX&amp;#174; Drug&amp;#45;Eluting Stent Technology For Review By FDA Panel</title><link>http://www.cookmedical.com/newsDetail.do?id=7227</link><description>Bloomington, IN &amp;#8211; September 16, 2011 &amp;#8211; Cook Medical will present data supporting the submission for its Zilver&amp;#174; PTX&amp;#174; Drug&amp;#45;Eluting Stent in the superficial femoral artery &amp;#40;SFA&amp;#41; to the Food and Drug Administration&amp;#8217;s &amp;#40;FDA&amp;#41; Circulatory System Devices Panel of the Medical Devices Advisory Committee on October 13, 2011. Stanford University physician Michael Dake, M.D., the global principal investigator of Cook Medical&amp;#8217;s Zilver PTX Drug&amp;#45;Eluting Stent clinical study, will present and highlight the data points.</description><author>David McCarty</author><pubDate>Mon, 19 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Launches Otrieva&amp;#8482; Tapered Ovum Aspiration Needle for Follicle Collection</title><link>http://www.cookmedical.com/newsDetail.do?id=7224</link><description>Bloomington, Ind. &amp;#8211; A new needle for ovum collection is now available to reproductive endocrinologists and embryologists: the Otrieva&amp;#8482; Tapered Ovum Aspiration Needle, which Cook Medical launches today. The Otrieva needle features a tapered bevel designed to allow precise ovum collection and less pain and bleeding during aspiration, as clinical studies of similar devices have demonstrated.</description><author>Caitlin Wenz</author><pubDate>Mon, 12 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Launches World&amp;#39;s First Stent Engineered Specifically for Use in the Iliofemoral Veins</title><link>http://www.cookmedical.com/newsDetail.do?id=7226</link><description>Munich, Germany, September 10, 2011 &amp;#8211; Cook Medical, a world leader in minimally invasive medical technologies, has launched the world&amp;#39;s first&amp;#45;ever stent designed and approved specifically to treat symptomatic iliofemoral venous outflow obstruction.</description><author>Linda Murphy</author><pubDate>Sat, 10 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Applauds AdvaMed Report That Medical Device Excise Tax Would Cost US 43,000 Jobs, Stifle Innovation and Limit Patient Access to New Medical Technologies</title><link>http://www.cookmedical.com/newsDetail.do?id=7225</link><description>Bloomington, Ind., September 9, 2011 &amp;#8211; On the heels of President Obama&amp;#8217;s speech to Congress about the critical need to accelerate US job growth, Cook Medical today applauded a new study from AdvaMed demonstrating that a new medical device excise tax would cost the US jobs, stifle innovation and limit patient access to new medical technologies.</description><author>David McCarty</author><pubDate>Fri, 9 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Supports the FDA&amp;#39;s Evaluation of Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse, but Urges Further Analysis </title><link>http://www.cookmedical.com/newsDetail.do?id=7223</link><description>Bloomington, Ind., September 7, 2011 &amp;#8212; Cook Medical supports the FDA&amp;#39;s efforts to protect women&amp;#39;s health and its review of the issues surrounding the use of surgical mesh for the treatment of pelvic floor disorders. We commend the FDA&amp;#39;s support of open scientific discussion of the effectiveness of transvaginal surgical mesh placement for pelvic organ prolapse repair. </description><author>Marsha Lovejoy</author><pubDate>Wed, 7 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Launches New Global Physician Education Programs for Urology </title><link>http://www.cookmedical.com/newsDetail.do?id=7222</link><description>Bloomington, Ind., September 1, 2011 &amp;#8211; Urologists around the globe will soon have access to an interactive and collaborative training program, as Cook Medical officials announced the launch of their Urology division&amp;#39;s physician education program, a part of a companywide Vista Collaboration and Learning Program.</description><author>Caitlin Wenz</author><pubDate>Thu, 1 Sep 2011 00:00:00 EDT</pubDate></item><item><title>Cook Medical Brings Portable Imaging System to Urologists with Launch of endogo&amp;#174; HD</title><link>http://www.cookmedical.com/newsDetail.do?id=7220</link><description>Bloomington, Ind., August 22, 2011 &amp;#8211; Cook Medical recently launched the endogo&amp;#174; HD Portable Endoscopic Imaging System by Envisionier Medical Technology, Inc. The endogo HD has the ability to capture, store and share endoscopic images, making it possible for doctors to share information with patients instantly, simplify collaboration between colleagues and potentially reduce costs by eliminating the need for repeat procedures.</description><author>Caitlin Wenz</author><pubDate>Mon, 22 Aug 2011 00:00:00 EDT</pubDate></item></channel></rss>


